| Adverse reactions to complementary medicines: the Australian pharmacy experience. | |
| | |
MedLine Citation:
|
PMID: 20636677 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: The primary aim was to determine the prevalence of adverse reactions to over-the-counter complementary medicines and their severity, as described by consumers. Secondary aims were to identify consumers' reporting behaviours and understanding of the AUST L designation on product labels. METHODS: An anonymous, self-administered survey was completed by randomly selected pharmacy customers at 60 community pharmacy locations between August 2008 and February 2009. KEY FINDINGS: Of the 1121 survey participants (response rate 62%), 72% had used a complementary medicine product in the previous 12 months, and 7% of this group (n = 55) reported having experienced an adverse reaction at some time. Of these, 71% described the reaction as mild and not requiring treatment, 22% as moderate and/or requiring advice from a healthcare professional and 7% (n = 4) described it as severe and requiring hospitalisation. If they were to report the reaction, it was most commonly to a medical practitioner. Most (88%) of complementary medicine consumers had never noticed the term 'AUST L'. CONCLUSIONS: Complementary medicines are widely used by pharmacy customers. Adverse reactions to these products are under-reported to healthcare authorities. Most adverse reactions are mild and serious reactions are rare. Customers have little awareness of the designation AUST L. |
| | |
Authors:
|
Lesley A Braun; Evilin Tiralongo; Jenny M Wilkinson; Susan Poole; Ondine Spitzer; Michael Bailey; Michael Dooley |
Related Documents
:
|
11816777 - Complementary and alternative medicine: what's it all about? 19718447 - Linguistic processing and classification of semi structured bibliographic data on compl... 9820257 - Trends in alternative medicine use in the united states, 1990-1997: results of a follow... 20665367 - Biosynthesis and therapeutic properties of lavandula essential oil constituents. 21326487 - Use of the interlock fibered idc occlusion system in clinical practice. 19914397 - Progress towards personalized medicine. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The International journal of pharmacy practice Volume: 18 ISSN: 0961-7671 ISO Abbreviation: Int J Pharm Pract Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-19 Completed Date: 2010-09-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9204243 Medline TA: Int J Pharm Pract Country: England |
Other Details:
|
Languages: eng Pagination: 242-4 Citation Subset: IM |
Affiliation:
|
Cardiothoracic Surgical Research Unit, Department of Surgery, Monash University Alfred Hospital, Melbourne. l.braun@alfred.org.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adverse Drug Reaction Reporting Systems* Australia Community Pharmacy Services Complementary Therapies / adverse effects* Drug Labeling Hospitalization / statistics & numerical data Humans Prevalence Questionnaires Severity of Illness Index |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Continuing professional pharmacy development needs assessment of Qatar pharmacists.
Next Document: Is there variability in drug release and physical characteristics of amiodarone chloride from differ...